Topic
Pharmaceuticals
996 published works
Spicy IP
Specific Comments on the IPO’s Draft Pharmaceutical Guidelines (2026)
There is no easier way to put it – the IPO’s Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026 (“2026 Draft Guidelines”) released 15 days…
Substance Law Blog
EU-GMP & GACP Certification for Canadian Cannabis Producers
By Anton Dnovo
GACP and EU-GMP Certification for Cannabis Growers and Producers in Canada Canadian cannabis businesses looking to export into regulated pharmaceutical markets typically need to navigate two related but distinct quality…
The IPKat
Patent Litigation Europe returns to Amsterdam with IPKat readers’ discount
Kats of AmsterdamThe Katfriends at Kisaco Research wish to inform IPKat readers that their Patent Litigation Europe event is returning to the Beurs van Berlage in Amsterdam on 18-20 January…
Arnold & Porter: News & Perspectives
Root Causes: Updates and Insights on Quality and Inspections
We are happy to launch a new newsletter, Root Causes: Updates and Insights on Quality and Inspections. The newsletter, which will come out roughly monthly, will discuss new developments in…
RF EMerge
The Evolving Law of Enablement: Federal Circuit Decisions in Wyeth and Teva Form a “Yin and Yang” Framework
By Aydin H. Harston, Anh-Thu Lam
Two Federal Circuit decisions, three months apart, analyzed enablement of similarly broad method-of-treatment claims, but reached opposite outcomes. In April, the court reversed a JMOL of invalidity and reinstated a…
Botinha & Cabral - International Business
How to Register Medicine in Brazil
By Bootie
Entering the Brazilian pharmaceutical market usually looks straightforward on paper until the first regulatory gap appears. For foreign manufacturers and life sciences companies, understanding how to register medicine in Brazil…
Spicy IP
General Comment on the IPO’s Draft Pharmaceutical Guidelines (2026)
A few days ago, we had informed our readers that they could participate in the open call for comments and suggestions on the Draft Guidelines for Examination of Patent Applications…
Lathrop GPM
Federal Circuit Decision Affirms Written Description Support for Broad Crystalline Salt Genus Claims
By Lathrop GPM
In a precedential ruling on August 31, 2026, the U.S. Court of Appeals for the Federal Circuit affirmed a District of Delaware judgment that the claims of three Exelixis patents…
E-Justice India
Impact Of Globalization On the Pharmaceutical Industry
Author : Shruti Sharma The contemporary world within which we reside is interconnected in all spheres, whether it is in political, social, economic, or cultural. The pharmaceutical industry acts as…
India Corporate Law
Patchwork of Legal Classification: How Transdermal Patches reveal the fault lines in India’s Drug–Cosmetic Divide
By Biplab Lenin, Priyam Rajkumar, Pranjal Diler
Summary: This article explores the regulatory challenges surrounding acne and transdermal patches in India. An acne patch that promises to “reduce a blemish overnight” and a nicotine patch that delivers…